Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: Combination Nicotine Patch / Lorcaserin for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the combination of a nicotine patch with lorcaserin for smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorcaserin (lorcaserin)
  • Nicotine patch (nicotine patch)

Snippet

Sponsor: Duke University | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07